Back to search

Spain· ES:56535

NEATENOL DIU 100mg/5mg COMPRIMIDOS

A medicinal product containing atenolol + bendroflumetiazida, registered in Spain by Meda Pharma S.L..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedNEATENOL DIU 100mg/5mg COMPRIMIDOSATC—REGISTER NO.ES:56535PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
atenolol + bendroflumetiazida
Manufacturer
Meda Pharma S.L.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    963389
    28
    EUR 6.96

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Atenolol + bendroflumetiazida in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atenolol + bendroflumetiazida products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c07ae567-e53e-4c65-879f-684594e8f27d
GET /v1/drugs/c07ae567-e53e-4c65-879f-684594e8f27d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":517960800000,\"rev\":1707916323000}",
  "nregistro": "56535",
  "substance": "atenolol + bendroflumetiazida"
}

See everything about atenolol + bendroflumetiazida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.